Cargando…
Differential Actions of Muscarinic Receptor Subtypes in Gastric, Pancreatic, and Colon Cancer
Cancers arising from gastrointestinal epithelial cells are common, aggressive, and difficult to treat. Progress in this area resulted from recognizing that the biological behavior of these cancers is highly dependent on bioactive molecules released by neurocrine, paracrine, and autocrine mechanisms...
Autores principales: | Schledwitz, Alyssa, Sundel, Margaret H., Alizadeh, Madeline, Hu, Shien, Xie, Guofeng, Raufman, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658119/ https://www.ncbi.nlm.nih.gov/pubmed/34884958 http://dx.doi.org/10.3390/ijms222313153 |
Ejemplares similares
-
Potential Role for Combined Subtype-Selective Targeting of M(1) and M(3) Muscarinic Receptors in Gastrointestinal and Liver Diseases
por: Tolaymat, Mazen, et al.
Publicado: (2021) -
Mechanistic Clues Provided by Concurrent Changes in the Expression of Genes Encoding the M(1) Muscarinic Receptor, β-Catenin Signaling Proteins, and Downstream Targets in Adenocarcinomas of the Colon
por: Alizadeh, Madeline, et al.
Publicado: (2022) -
Selective Activation of M(1) Muscarinic Receptors Attenuates Human Colon Cancer Cell Proliferation
por: Sundel, Margaret H., et al.
Publicado: (2023) -
Muscarinic receptor signaling and colon cancer progression
por: Xie, Guofeng, et al.
Publicado: (2016) -
Muscarinic receptor agonist-induced βPix binding to β-catenin promotes colon neoplasia
por: Cheng, Kunrong, et al.
Publicado: (2023)